Trial intelligence / Profile preview

Magnesium Sulphate in Neonates With HIE

NCT04705142Phase 2Completed

Sponsor
Services Institute of Medical Sciences
Start
May 2019
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of magnesium sulfate in hypoxic-ischemic encephalopathy (HIE), sponsored by Services Institute of Medical Sciences. Started May 2019; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

hypoxic-ischemic encephalopathy (HIE)

Beyond the preview

Go deeper on NCT04705142.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04705142.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call